Haemonetics Corporation (HAE) /
The profitability of Haemonetics Corporation over the past 10 years
Chart Haemonetics Corporation: gross profit, operating income, net income, fiscal 2017–2026 Open the chart →Haemonetics Corporation reported net income of $97.31M in fiscal 2026, the latest fiscal year on file. That year it had gross profit of $787.59M and operating income of $156.73M. It reported a profit in 9 of the 10 years shown, and a loss in fiscal 2017. Its highest net income in these years was $167.68M, in fiscal 2025.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2026ended Mar 28, 2026 | $787.59M | $156.73M | $97.31M |
| 2025ended Mar 29, 2025 | $748.96M | $221.82M | $167.68M |
| 2024ended Mar 30, 2024 | $691.55M | $164.88M | $117.56M |
| 2023ended Apr 1, 2023 | $615.1M | $156.03M | $115.4M |
| 2022ended Apr 2, 2022 | $505.5M | $80.75M | $43.38M |
| 2021ended Apr 3, 2021 | $397.84M | $89.75M | $79.47M |
| 2020ended Mar 28, 2020 | $484.51M | $103.35M | $76.53M |
| 2019ended Mar 30, 2019 | $417.54M | $83.55M | $55.02M |
| 2018ended Mar 31, 2018 | $411.91M | $56.16M | $45.57M |
| 2017ended Apr 1, 2017 | $378.49M | -$19.38M | -$26.27M |
Fiscal years as Haemonetics Corporation reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Haemonetics Corporation
- The revenue of Haemonetics Corporation
- The cash flow of Haemonetics Corporation
- The debt of Haemonetics Corporation
- All of Haemonetics Corporation's financials, charted
Companies of a similar size
- BXSLBlackstone Secured Lending Fund
- SRRKSCHOLAR ROCK HOLDING CORPORATION
- EXPEAGLE MATERIALS INC
- NJRNEW JERSEY RESOURCES CORPORATION
- CGONCG Oncology, Inc.
Not investment advice. This page shows what Haemonetics Corporation filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.